Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
    • Medicines for use outside the EU
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Support to research
    • Contact
    • Legal
    • Glossary
    • Search tips
    • FAQs
    • Brexit: UK withdrawal from EU

COVID-19 pandemic

All info here

QUICK LINKS

  • Latest updates
  • Treatments and vaccines
  • Guidance for developers and companies
  • COVID-19 vaccines: key facts
  • Full assessment report for COVID-19 Vaccine Moderna
    COVID-19 vaccine - marketing authorisation slider
    COVID-19 |Vaccines

    Full assessment report for COVID-19 Vaccine Moderna

  • Full assessment report for COVID-19 Vaccine Moderna
    COVID-19 vaccine - marketing authorisation slider
    COVID-19 |Vaccines

    Full assessment report for COVID-19 Vaccine Moderna

    EMA has published the full assessment report for COVID-19 Vaccine Moderna, the second COVID-19 vaccine authorised in the EU.

  • Human medicines: highlights of 2020
    Human medicines highlights report 2020 slider
    MEDICINES |Highlights

    Human medicines: highlights of 2020

  • Human medicines: highlights of 2020
    Human medicines highlights report 2020 slider
    MEDICINES |Highlights

    Human medicines: highlights of 2020

    In 2020, EMA recommended 97 medicines for authorisation. Read more about the Agency’s key recommendations on the authorisation and safety monitoring of medicines in our visual overview.

  • Veterinary medicines: highlights of 2020
    Veterinary medicines highlights 2020 slider
    MEDICINES |Highlights

    Veterinary medicines: highlights of 2020

  • Veterinary medicines: highlights of 2020
    Veterinary medicines highlights 2020 slider
    MEDICINES |Highlights

    Veterinary medicines: highlights of 2020

    EMA recommended 20 veterinary medicines for authorisation in 2020. Check out our visual overview of key recommendations on the authorisation and safety monitoring of veterinary medicines.

  • ICMRA statement for healthcare professionals published
    ICMRA statement for healthcare professionals slider
    COVID-19 |International collaboration

    ICMRA statement for healthcare professionals published

  • ICMRA statement for healthcare professionals published
    ICMRA statement for healthcare professionals slider
    COVID-19 |International collaboration

    ICMRA statement for healthcare professionals published

    EMA has endorsed a statement developed by ICMRA to inform and help healthcare professionals answer questions about the evaluation, approval and monitoring of COVID-19 vaccines.

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    22/01/2021

    Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 19-20 January 2021

    CVMP adopts its workplan for 2021 and its strategy on antimicrobials for 2021-2025 CVMP opinions on veterinary medicinal products The Committee adopted by consensus a positive opinion for a type II variation application for Exzolt (fluralaner ) to...

  • List item
    21/01/2021

    Veterinary medicines: highlights of 2020

    EMA has published an overview of its key recommendations of 2020 regarding the authorisation and safety monitoring of veterinary medicines. In 2020, EMA recommended 20 medicines for marketing authorisation, including 13 with a new active substance...

  • List item
    21/01/2021

    Human medicines: highlights of 2020

    EMA has published an overview of its key recommendations in 2020 on the authorisation and safety monitoring of medicines for human use. In 2020, EMA recommended 97 medicines for marketing authorisation. Of these, 39 had a new active substance which...

  • List item
    19/01/2021 COVID-19

    Global regulators highlight key role of healthcare professionals in fostering confidence in COVID-19 vaccines

    EMA has endorsed a joint statement published today by the International Coalition of Medicines Regulatory Authorities (ICMRA) to inform and help healthcare professionals answer questions about the evaluation, approval and monitoring of safe,...

  • List item
    15/01/2021

    Cyberattack on EMA - update 5

    The ongoing investigation of the cyberattack on EMA revealed that some of the unlawfully accessed documents related to COVID-19 medicines and vaccines have been leaked on the internet. This included internal/confidential email correspondence dating...

  • List item
    15/01/2021 COVID-19

    Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2021

    First monthly summary safety report for COVID-19 vaccine Comirnaty Starting this month, EMA’s safety committee (PRAC) will evaluate summary safety reports submitted monthly by marketing authorisations holders of COVID-19 vaccines. The first such...

  • Load more news

Information for

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EU Veterinary Medicinal Product Database

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
About
  • Who we are
  • Human regulatory
  • Veterinary regulatory
  • Committees
Ask EMA
  • Send a question
  • FAQs
  • Access to documents
Links
  • Legal
  • Privacy
  • Complaints
  • Contacts
  • Glossary
  • Search tips
  • Business hours and holidays
Contact

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

For delivery address, see:
How to find us

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. EMA is in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed.
RSS feed Twitter YouTube LinkedIn
© 1995-2021 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag